| 1 |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020[J]. CA Cancer J Clin, 2020, 70(1): 7-30.
|
| 2 |
Obuch JC, Ahnen DJ. Colorectal cancer: Genetics is changing everything[J]. Gastroenterol Clin North Am, 2016, 45(3): 459-476.
|
| 3 |
Schmitt AM, Chang HY. Long Noncoding RNAs in cancer pathways[J]. Cancer Cell, 2016, 29(4): 452-463.
|
| 4 |
He X, Ou C, Xiao Y, et al. LncRNAs: key players and novel insights into diabetes mellitus[J]. Oncotarget, 2017, 8(41): 71325-71341.
|
| 5 |
Bazzini AA, Johnstone TG, Christiano R, et al. Identification of small ORFs in vertebrates using ribosome footprinting and evolutionary conservation[J]. Embo J, 2014, 33(9): 981-993.
|
| 6 |
Zhao CH, Bai XF, Hu XH. Knockdown of lncRNA XIST inhibits hypoxia-induced glycolysis, migration and invasion through regulating miR-381-3p/NEK5 axis in nasopharyngeal carcinoma[J]. Eur Rev Med Pharmacol Sci, 2020, 24(5): 2505-2517.
|
| 7 |
Zhang M, Wang F, Xiang Z, et al. LncRNA XIST promotes chemoresistance of breast cancer cells to doxorubicin by sponging miR-200c-3p to upregulate ANLN[J]. Clin Exp Pharmacol Physiol, 2020, 47(8): 1464-1472.
|
| 8 |
Dong Z, Liu H, Zhao G. Long noncoding RNA SNHG6 promotes proliferation and inhibits apoptosis in non-small cell lung cancer cells by regulating miR-490-3p/RSF1 axis[J]. Cancer Biother Radiopharm, 2020, 35(5): 351-361.
|
| 9 |
Wang Y, Nie H, He X, et al. The emerging role of super enhancerderived noncoding RNAs in human cancer[J]. Theranostics, 2020, 10(24): 11049-11062.
|
| 10 |
Zhang YT, Yang GY. LncRNA SNHG17 acts as a ceRNA of miR-324-3p to contribute the progression of osteosarcoma[J]. J Biol Regul Homeost Agents, 2020, 34(4): 1529-1533.
|
| 11 |
Zheng ZJ, Liu Y, Wang HJ, et al. LncRNA SNHG17 promotes proliferation and invasion of ovarian cancer cells through up-regulating FOXA1[J]. Eur Rev Med Pharmacol Sci, 2020, 24(18): 9282-9289.
|
| 12 |
Tong F, Guo J, Miao Z, et al. LncRNA SNHG17 promotes the progression of oral squamous cell carcinoma by modulating miR-375/PAX6 axis[J]. Cancer Biomark, 2021, 30(1): 1-12.
|
| 13 |
Wu G, Hao C, Qi X, et al. LncRNA SNHG17 aggravated prostate cancer progression through regulating its homolog SNORA71B via a positive feedback loop[J]. Cell Death Dis, 2020, 11(5): 393.
|
| 14 |
Li H, Li T, Huang D, et al. Long noncoding RNA SNHG17 induced by YY1 facilitates the glioma progression through targeting miR-506-3p/CTNNB1 axis to activate Wnt/β-catenin signaling pathway[J]. Cancer Cell Int, 2020, 20: 29.
|
| 15 |
Ni W, Yao S, Zhou Y, et al. Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m6A reader YTHDF3[J]. Mol Cancer, 2019, 18(1): 143.
|
| 16 |
Tang J, Yan T, Bao Y, et al. LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc[J].Nat Commun, 2019, 10(1): 3499.
|
| 17 |
Wu Y, Yang X, Chen Z, et al. m6A-induced lncRNA RP11 triggers the dissemination of colorectal cancer cells via upregulation of Zeb1[J].Mol Cancer, 2019, 18(1): 87.
|
| 18 |
Li H, Rokavec M, Jiang L, et al. Antagonistic effects of p53 and HIF1A on microRNA-34a regulation of PPP1R11 and STAT3 and hypoxia-induced epithelial to mesenchymal transition in colorectal cancer cells[J]. Gastroenterology, 2017, 153(2): 505-520.
|
| 19 |
Wei C, Yang C, Wang S, et al. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis[J]. Mol Cancer, 2019, 18(1): 64.
|
| 20 |
Lin X, Wang S, Sun M, et al. miR-195-5p/NOTCH2-mediated EMT modulates IL-4 secretion in colorectal cancer to affect M2-like TAM polarization[J]. J Hematol Oncol, 2019, 12(1): 20.
|